TSX-V:LOVE • CA13765U2002
The current stock price of LOVE.CA is 1.83 CAD. In the past month the price decreased by -7.58%. In the past year, price increased by 41.86%.
ChartMill assigns a technical rating of 5 / 10 to LOVE.CA. When comparing the yearly performance of all stocks, LOVE.CA turns out to be only a medium performer in the overall market: it outperformed 64.78% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA. LOVE.CA has an average financial health and profitability rating.
Over the last trailing twelve months LOVE.CA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 76.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.51% | ||
| ROA | 6.79% | ||
| ROE | 10.62% | ||
| Debt/Equity | 0.29 |
5 analysts have analysed LOVE.CA and the average price target is 3.57 CAD. This implies a price increase of 95.08% is expected in the next year compared to the current price of 1.83.
For the next year, analysts expect an EPS growth of 60% and a revenue growth 16.54% for LOVE.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| JWEL | JAMIESON WELLNESS INC | 16.42 | 1.581B |
View all stocks in the Personal Care Products Industry | View all stocks in the Consumer Staples Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find more growth stocks the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.
CANNARA BIOTECH INC
Suite 2050 - 1055, West Georgia Street
Vancouver BRITISH COLUMBIA V6E 3P3 CA
Employees: 13
Phone: 15149139136.0
Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.
The current stock price of LOVE.CA is 1.83 CAD. The price decreased by -3.17% in the last trading session.
LOVE.CA does not pay a dividend.
LOVE.CA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
LOVE.CA stock is listed on the TSX Venture Exchange exchange.
CANNARA BIOTECH INC (LOVE.CA) currently has 13 employees.